News Overview

The public issue is priced at a price band of Rs559 per share to Rs587 per share respectively having a face value of Rs10 each.

Glenmark Pharmaceuticals rose 1.32% to Rs 417 after the drug maker and its US arm, Glenmark Pharmaceuticals Inc. have reached a settlement agreement with Pfizer Inc., PF Prism C.V., and PF Prism IMB B.V. (Pfizer) for Axitinib Tablets.

Lender asserts to be the first company in GIFT City to provide these products

Glenmark had previously announced that the United States Food and Drug Administration (USFDA) had tentatively approved their generic Axitinib Tablets.

The Delhivery share post-IPO lock-in period of six months came to an end on November 20

Finvasia Group Opens a New Office in India’s Financial Capital, Mumbai

Basic materials stocks were trading in the positive zone, with the S&P BSE Commodities index rising 34.15 points or 0.62% at 5573.36 at 09:45 IST.

Capital Goods stocks were trading with gains, with the S&P BSE Capital Goods index increasing 137.75 points or 0.41% at 33464.52 at 09:45 IST.

Industrials stocks were trading in green, with the S&P BSE Industrials index rising 23.27 points or 0.34% at 6805.09 at 09:45 IST.

The company's IPO was 32 times subscribed, with the stock reaching a high of Rs 476 and a low of Rs 440.2 on the NSE